{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:18:12Z","timestamp":1790205492918,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1097\/01.fpc.0000114771.78957.cb","type":"journal-article","created":{"date-parts":[[2004,7,28]],"date-time":"2004-07-28T08:01:55Z","timestamp":1091001715000},"page":"487-499","source":"Crossref","is-referenced-by-count":78,"title":["Human UGT1A6 pharmacogenetics"],"prefix":"10.1097","volume":"14","author":[{"given":"Swati","family":"Nagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J","family":"Zalatoris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210213","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.286.5439.487","article-title":"Pharmacogenomics: translating functional genomics into rational therapeutics.","volume":"286","author":"Evans","year":"1999","journal-title":"Science"},{"key":"R3-2-20210213","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease.","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R4-2-20210213","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008571-199708000-00001","article-title":"The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.","volume":"7","author":"Mackenzie","year":"1997","journal-title":"Pharmacogenetics"},{"key":"R5-2-20210213","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(96)91273-8","article-title":"Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome.","volume":"347","author":"Monaghan","year":"1996","journal-title":"Lancet"},{"key":"R6-2-20210213","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00008571-199712000-00007","article-title":"Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications.","volume":"7","author":"Ciotti","year":"1997","journal-title":"Pharmacogenetics"},{"key":"R7-2-20210213","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00008571-200010000-00006","article-title":"Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene.","volume":"10","author":"Guillemette","year":"2000","journal-title":"Pharmacogenetics"},{"key":"R8-2-20210213","first-page":"207","article-title":"Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene.","volume":"9","author":"Levesque","year":"1999","journal-title":"Pharmacogenetics"},{"key":"R9-2-20210213","first-page":"475","article-title":"Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs.","volume":"264","author":"Jin","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"R10-2-20210213","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00008571-200011000-00002","article-title":"Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance.","volume":"10","author":"Bhasker","year":"2000","journal-title":"Pharmacogenetics"},{"key":"R11-2-20210213","first-page":"889","article-title":"Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance, Clin Chem Lab M","volume":"38","author":"Mackenzie","year":"2000","journal-title":"ed"},{"key":"R12-2-20210213","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00008571-200106000-00011","article-title":"Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.","volume":"11","author":"Gong","year":"2001","journal-title":"Pharmacogenetics"},{"key":"R13-2-20210213","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/S0021-9258(19)50724-4","article-title":"A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini.","volume":"267","author":"Ritter","year":"1992","journal-title":"J Biol Chem"},{"key":"R14-2-20210213","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0079-6603(08)60882-X","article-title":"Gene structure at the human UGT1 locus creates diversity in isozyme structure, substrate specificity, and regulation.","volume":"51","author":"Owens","year":"1995","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"R15-2-20210213","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1081\/DMR-100101944","article-title":"Structural and functional studies of UDP-glucuronosyltransferases.","volume":"31","author":"Radominska-Pandya","year":"1999","journal-title":"Drug Metab Rev"},{"key":"R16-2-20210213","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/mol.52.2.212","article-title":"Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue.","volume":"52","author":"Strassburg","year":"1997","journal-title":"Mol Pharmacol"},{"key":"R17-2-20210213","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/abbi.1999.1155","article-title":"Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate.","volume":"365","author":"King","year":"1999","journal-title":"Arch Biochem Biophys"},{"key":"R18-2-20210213","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/0006-2952(93)90437-2","article-title":"Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases.","volume":"45","author":"Bock","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"R19-2-20210213","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0006-2952(94)90198-8","article-title":"Radiation inactivation analysis of microsomal UDP-glucuronosyltransferases catalysing mono- and diglucuronide formation of 3,6-dihydroxybenzo(a)pyrene and 3,6-dihydroxychrysene.","volume":"48","author":"Gschaidmeier","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"R20-2-20210213","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1021\/bi9702344","article-title":"Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes.","volume":"36","author":"Ikushiro","year":"1997","journal-title":"Biochemistry"},{"key":"R21-2-20210213","doi-asserted-by":"crossref","first-page":"26913","DOI":"10.1074\/jbc.272.43.26913","article-title":"UDP-glucuronosyltransferase, the role of the amino terminus in dimerization.","volume":"272","author":"Meech","year":"1997","journal-title":"J Biol Chem"},{"key":"R22-2-20210213","doi-asserted-by":"crossref","first-page":"42108","DOI":"10.1074\/jbc.M106742200","article-title":"Homodimerization of human bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) and its functional implications.","volume":"276","author":"Ghosh","year":"2001","journal-title":"J Biol Chem"},{"key":"R23-2-20210213","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/abbi.1998.0750","article-title":"Determinants of UDP glucuronosyltransferase membrane association and residency in the endoplasmic reticulum.","volume":"356","author":"Meech","year":"1998","journal-title":"Arch Biochem Biophys"},{"key":"R24-2-20210213","doi-asserted-by":"crossref","first-page":"31401","DOI":"10.1074\/jbc.274.44.31401","article-title":"An internal signal sequence mediates the targeting and retention of the human UDP-glucuronosyltransferase 1A6 to the endoplasmic reticulum.","volume":"274","author":"Ouzzine","year":"1999","journal-title":"J Biol Chem"},{"key":"R25-2-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1432-1327.1998.2540001.x","article-title":"Protein translocation into the endoplasmic reticulum (ER) - two similar routes with different modes.","volume":"254","author":"Kalies","year":"1998","journal-title":"Eur J Biochem"},{"key":"R26-2-20210213","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.97.19.10483","article-title":"Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.","volume":"97","author":"Drysdale","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-2-20210213","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00008571-200112000-00001","article-title":"Resequencing the sulfotransferase SULT1 gene provides new insights, while illuminating challenges that lie ahead for pharmacogenomics.","volume":"11","author":"Evans","year":"2001","journal-title":"Pharmacogenetics"},{"key":"R28-2-20210213","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/nar\/19.2.408","article-title":"A rapid procedure for extracting genomic DNA from leukocytes.","volume":"19","author":"John","year":"1991","journal-title":"Nucl Acids Res"},{"key":"R29-2-20210213","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0003-9861(71)90213-X","article-title":"On the inhibitory action of mersalyl on microsomal drug oxidation: a rigid organization of the electron transport chain.","volume":"143","author":"Franklin","year":"1971","journal-title":"Arch Biochem Biophys"},{"key":"R30-2-20210213","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0076-6879(81)77022-8","article-title":"4-Nitrophenol UDPglucuronyltransferase (Rat Liver).","volume":"77","author":"Burchell","year":"1981","journal-title":"Methods Enzymol"},{"key":"R32-2-20210213","first-page":"998","article-title":"Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.","volume":"299","author":"Court","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"R33-2-20210213","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/dmd.30.6.734","article-title":"Quantitative structure activity relationships for the glucuronidation of simple phenols by expressed human UGT1A6 and UGT1A9.","volume":"30","author":"Ethell","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"R34-2-20210213","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0014-5793(92)81266-O","article-title":"Characterisation of a human bilirubin UDP-glucuronosyltransferase stably expressed in hamster lung fibroblast cell cultures.","volume":"308","author":"Sutherland","year":"1992","journal-title":"FEBS Lett"},{"key":"R35-2-20210213","first-page":"507","article-title":"Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3.","volume":"26","author":"Green","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"R36-2-20210213","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/dmd.31.1.133","article-title":"Validation of serotonin (5-hydroxytryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6.","volume":"31","author":"Krishnaswamy","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"R37-2-20210213","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/hmg\/4.7.1183","article-title":"Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.","volume":"4","author":"Koiwai","year":"1995","journal-title":"Hum Mol Genet"},{"key":"R38-2-20210213","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/hmg\/5.5.645","article-title":"Crigler-Najjar syndrome type II is inherited both as a dominant and as a recessive trait.","volume":"5","author":"Koiwai","year":"1996","journal-title":"Hum Mol Genet"},{"key":"R39-2-20210213","first-page":"647","article-title":"Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium.","volume":"54","author":"Strassburg","year":"1998","journal-title":"Mol Pharmacol"},{"key":"R40-2-20210213","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0006-2952(97)00347-X","article-title":"Drug-metabolizing enzymes in pharyngeal mucosa and in oropharyngeal cancer tissue.","volume":"54","author":"Ullrich","year":"1997","journal-title":"Biochem Pharmacol"}],"container-title":["Pharmacogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.fpc.0000114771.78957.cb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:40:32Z","timestamp":1620938432000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008571-200408000-00002"}},"subtitle":["identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells"],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.fpc.0000114771.78957.cb","relation":{},"ISSN":["0960-314X"],"issn-type":[{"value":"0960-314X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}